Impact of Primary Tumor Sidedness and Sex on Prognosis and Anti-EGFR Antibody Efficacy in BRAF-Mutant Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI
ESMO Open 2024 Aug 21;9(9)103677, AHS Alig, DP Modest, S Stintzing, K Heinrich, M Geissler, L Fischer von Weikersthal, T Decker, U Vehling-Kaiser, S Held, N Moosmann, A Stahler, A Tannapfel, C Giessen-Jung, A Jung, L Weiss, V HeinemannFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.